Skip to main content
Search results
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selpercatinib-medullary-thyroid-cancer-ret-mutation
7 months ago -
...cabozantinib (140 mg once daily) or vandetanib (300 mg once daily). Patients were...the control arm (cabozantinib vs. vandetanib). The main efficacy ...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pralsetinib-ret-altered-thyroid-cancers
8 months ago -
...who received prior cabozantinib or vandetanib. The ORR for these patients was 60%...not receive prior cabozantinib or vandetanib. The ORR was 66% (95% ...
https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/january-march-2020-potential-signals-serious-risksnew-safety-information-identified-fda-adverse
about 1 month ago -
Cabometyx (cabozantinib) Caprelsa (vandetanib) Cometriq (cabozantinib) Cyramza
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selpercatinib-lung-and-thyroid-cancers-ret-gene-mutations-or-fusions
8 months ago -
...previously treated with cabozantinib, vandetanib, or both, and patients who had not
https://www.fda.gov/media/183805/download
12 months ago -
...gov/drugsa tfda_docs/psg/PSG_021729.pdf Vandetanib QT interval prolongation potential
https://www.fda.gov/drugs/drug-interactions-labeling/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems
10 months ago -
...2D6 moderate sensitive substrate vandetanib MATE1; MATE2-K inhibitor vardenafil
https://www.fda.gov/media/86040/download
about 12 years ago -
Caprelsa (vandetanib) REMS...Caprelsa (vandetanib) REMS IMPORTANT DRUG WARNING SUBJECT: Serious Risks of...and Sudden death for Caprelsa® (vandetanib ...
https://www.fda.gov/media/185465/download
2 months ago -
Change With Clinical Data CAPRELSA (VANDETANIB) GENZYME CORP S 3/7/2024 NDA 022433
https://www.fda.gov/media/160618/download
almost 3 years ago -
...alert in the Heart Failure model. VANDETANIB, anti-cancer CILOSTAZOL, Hematologic
https://www.fda.gov/media/178001/download
12 months ago -
SG_203975.pdf 2/15/2024 Other N/A 112 Q2 Vandetanib; Revised Draft Guidance for Industry
https://www.fda.gov/media/178811/download
almost 3 years ago -
Hypertension mild CAPRELSA VANDETANIB VANDETANIB Mixed bw most prolong the QT
https://www.fda.gov/media/170268/download
almost 2 years ago -
Targeted Phase I/II trial of ZD6474 (Vandetanib CAPRELSA) Plus the Proteasome Inhibitor... Gramza AW. Phase I/II Trial of Vandetanib and Bortezomib in ...
https://www.fda.gov/drugs/development-approval-process-drugs/drug-trials-snapshots-retevmo
almost 5 years ago -
Previously Treated with Cabozantinib or Vandetanib RETEVMO (n = 55) Overall Response...Efficacy Results in Cabozantinib and Vandetanib-naïve ...
https://www.fda.gov/media/149017/download
almost 4 years ago -
...1102 0 1 6 24 48 0.0 0.5 1.0 1.5 Vandetanib 3x No rm al iz ed C I 1102 0 1 6
https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-patients-lung-and-thyroid-cancers-certain-genetic-mutation-or-fusion
almost 5 years ago -
...previously treated with cabozantinib, vandetanib or both (types of chemotherapy),...prior treatment with cabozantinib or vandetanib. The ORR for the ...
https://www.fda.gov/media/174295/download
over 1 year ago -
...inhibitor UMBRALISIB kinase inhibitor VANDETANIB kinase inhibitor VEMURAFENIB kinase
https://www.fda.gov/media/177252/download
7 months ago -
...inhibitor UMBRALISIB kinase inhibitor VANDETANIB kinase inhibitor VEMURAFENIB kinase
https://www.fda.gov/media/134793/download
over 5 years ago -
...2012 2013 2014 2015 1.Ipilimumab 2.Vandetanib 3.Abiraterone 4.Rivaroxaban 5.Vemurafenib
https://www.fda.gov/media/159488/download
almost 3 years ago -
...inhibitor UMBRALISIB kinase inhibitor VANDETANIB kinase inhibitor VEMURAFENIB kinase
https://www.fda.gov/media/159446/download
almost 3 years ago -
...inhibitor UMBRALISIB kinase inhibitor VANDETANIB kinase inhibitor VEMURAFENIB kinase
